comparemela.com

Latest Breaking News On - Expanded indication - Page 1 : comparemela.com

May is Hepatitis Awareness Month

Hepatitis Awareness Month is designed to raise awareness of viral hepatitis and promote testing and vaccination while decreasing the stigma against the virus.

United statesGilead sciences incUs preventive services taskGilead sciencesHepatitis awareness monthHepatitis testingServices task forceOngoing global managementExpanded indicationTenofovir alafenamideDisease focusHepatitisc treatment

Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results

Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding.

United statesAdempas verquvoPatritumab deruxtecanRobertm davisDaiichi sankyo biologicsDaiichi sankyoHuman healthAfferent pharmaceuticalsExchange commissionMerck co incRestructuring programModerna incDrug administrationNet income attributable to merck co incPrometheus biosciences incHarpoon therapeutics inc

SI-Bone gets clearance for smaller version of spine implant

SI-Bone earned FDA 510(k) clearance of the iFuse Bedrock Granite implant system in a smaller diameter, according to a Jan. 30 news release.

Technology paymentFuse bedrock graniteBreakthrough device designationNew technology add on paymentSi boneDa 510k clearanceMaller diameterExpanded indicationPediatric patients1 trajectorySacroiliac fusion

U S Food and Drug Administration Approves BioMarin s VOXZOGO® (vosoritide) for Children Under 5 Years with Achondroplasia

/PRNewswire/ BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today.

Andrew villaniTraci mccartyBiomarin rareconnectionsHank fuchsWilliam wilcoxCommittee for medicinal products human useBiomarin pharmaceutical incEuropean commissionEmory universityWorldwide researchEuropean medicines agencyDrug administrationExchange commissionExpanded indicationIncludes childrenBiomarin pharmaceutical

NeuroStar Achieves Milestone Regulatory Clearance in South Korea

First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ TechnologiesMALVERN, Pa., July 17, 2023 Neuronetics, Inc. , a medical technology company focused.

South koreaUnited statesSouth koreanKeithj sullivanNeurostar advanced therapy for mental healthNeuronetics incPublic healthMinistry of foodFirst international approval for expanded indicationOrganization of economic cooperationFirst international approvalExpanded indicationDrug safetyEconomic cooperationNeurostar advanced therapyGeneral population

vimarsana © 2020. All Rights Reserved.